Niche HIT Leader OmneDiem has established a strong leadership position in Histamine Intolerance management with DAOgest and a history of clinical research since 2000, presenting a compelling case to healthcare practitioners and dietary supplement retailers seeking HIT solutions.

Clinical Research Focus Continued investment in clinical research and education supports credibility and potential partnerships with health systems, clinics, and practitioners for product validation, education campaigns, and co-branded initiatives.

Multi Channel Reach A multi-channel approach positions OmneDiem to partner with distributors, retailers, practitioners, and consumers, enabling diversified sales opportunities across DTC, B2B, and educational channels.

Educational Advantage Extensive public education around HIT creates opportunities for collaborations in seminars, webinars, and content marketing with healthcare professionals and wellness platforms, driving adoption and trust.

Growth via Strategic Alliances With a US-exclusive HIT dietary supplement and a product line centered on digestive health, OmneDiem can pursue co-branding, private-labeling, and strategic alliances with allied wellness brands and gut health platforms to scale reach.